{"podcast":{"title":"KQED's Forum","slug":"kqed-s-forum-910728","podcast_index_feed_id":910728,"rss_url":"https://feeds.megaphone.fm/KQINC9557381633","website_url":"https://www.kqed.org/forum","image_url":"https://megaphone.imgix.net/podcasts/f7fab6b6-22d6-11eb-9a54-13d0154cc15e/image/KQED_Podcast_tiles_-_NPR_network_Forum.png?ixlib=rails-4.3.1&max-w=3000&max-h=3000&fit=crop&auto=format,compress","author":"KQED","episode_count":3439,"summary":"Forum tells remarkable and true stories about who we are and where we live. In the first hour, Alexis Madrigal convenes the diverse voices of the Bay Area, before turning to Mina Kim for the second hour to chronicle and center Californians’ experience. In an increasingly divided world, Mina and Alexis host conversations that inform, challenge and unify listeners with big ideas and different viewpoints. Want to call/submit your comments during our live Forum program Mon-Fri, 9am-11am? We'd love to hear from you! Please dial 866.SF.FORUM or (866) 733-6786 or email forum@kqed.org, tweet, or post on Facebook.","last_synced_at":"2026-07-25T18:21:19.316184+00:00","page_url":"https://stenobird.com/podcast/kqed-s-forum-910728"},"episode":{"title":"Forum from the Archives: Have We Learned How to Talk About GLP1s?","slug":"forum-from-the-archives-have-we-learned-how-to-talk-about-glp1s","published_at":"2026-06-30T18:00:00+00:00","page_url":"https://stenobird.com/podcast/kqed-s-forum-910728/forum-from-the-archives-have-we-learned-how-to-talk-about-glp1s","show_page_url":"https://stenobird.com/podcast/kqed-s-forum-910728","url":"https://www.podtrac.com/pts/redirect.mp3/pdst.fm/e/traffic.megaphone.fm/KQINC8342533622.mp3","audio_url":"https://www.podtrac.com/pts/redirect.mp3/pdst.fm/e/traffic.megaphone.fm/KQINC8342533622.mp3","summary":"An estimated one in eight Americans has now tried a GLP-1 medication like Ozempic or Wegovy: to lose weight, manage diabetes or experiment with anecdotal, off-label benefits. Yet GLP-1s can be hard to talk about — whether you want to ask someone if they take one, respond if you do, or discuss weight without dredging up unhealthy diet discourse. We’ll hear how you’re navigating these conversations in the age of GLP-1s. Tell us: How are GLP-1s showing up in your world? Guests: Diana Thiara, medical director, UCSF Weight Loss Management Program Whitney Casares, pediatrician; author, “Raising Body-Confident Kids” and “My One-Of A-Kind Body: The Ultimate Guide to Caring for Me” Angela Corral, senior editor, KQED’s The California Report; she has been been taking a GLP-1 for almost 2 years Learn more about your ad choices. Visit megaphone.fm/adchoices","meta_description":"An estimated one in eight Americans has now tried a GLP-1 medication like Ozempic or Wegovy: to lose weight, manage diabetes or experiment with anecdotal,…","key_points":[],"chapters":[],"topics":[],"duration_seconds":3346,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/kqed-s-forum-910728/episodes/forum-from-the-archives-have-we-learned-how-to-talk-about-glp1s/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/kqed-s-forum-910728/forum-from-the-archives-have-we-learned-how-to-talk-about-glp1s.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}